Search research articles
Contact Us
Filters
Showing results (51-60 of 66) with videos related to
Page
of 7
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 24, 2013
Population pharmacokinetics of intravenous polymyxin B in critically ill patients: implications for selection of dosage regimens
Ana M Sandri, Cornelia B Landersdorfer, Jovan Jacob, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 2, 2026
Global Survey on the Management of Multidrug-resistant Gram-negative Bacilli: Divergence of Practice Between High-Income Countries and the Rest of the World
Abi Manesh, Abdullah T Aslan, Mithun Mohan George, et al.
The American Journal of Tropical Medicine and Hygiene
|
July 27, 2022
Evaluation of Clinical Course of Gamma (P.1) Variant of Concern versus Lineages in Hospitalized Patients with COVID-19 in a Reference Center in Brazil
Alexandre P Zavascki, Tarsila Vieceli, Priscila Lamb Wink, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
November 23, 2021
Assessing the predictive performance of population pharmacokinetic models for intravenous polymyxin B in critically ill patients
Patrick O Hanafin, Roger L Nation, Marc H Scheetz, et al.
Antimicrobial Agents and Chemotherapy
|
April 17, 2019
Comparable Efficacy and Better Safety of Double β-Lactam Combination Therapy versus β‑Lactam plus Aminoglycoside in Gram-Negative Bacteria in Randomized, Controlled Trials
Yuanyuan Jiao, Bartolome Moya, Mong-Jen Chen, et al.
Infectious Diseases and Therapy
|
December 12, 2025
Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus Causing Healthcare-Associated Bloodstream Infections in Brazil: Results from A Prospective Countrywide Multicenter Study
Laura C Antochevis, Letícia O Sudbrack, Robson S Leão, et al.
Pharmacotherapy
|
February 3, 2019
International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)
Brian T Tsuji, Jason M Pogue, Alexandre P Zavascki, et al.
Infectious Diseases and Therapy
|
December 15, 2023
A Randomized, Open-Label, Non-inferiority Clinical Trial Assessing 7 Versus 14 Days of Antimicrobial Therapy for Severe Multidrug-Resistant Gram-Negative Bacterial Infections: The OPTIMISE Trial Protocol
Beatriz Arns, Jaqueline Driemeyer C Horvath, Gabriela Soares Rech, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
May 22, 2023
A population pharmacokinetic model of polymyxin B based on prospective clinical data to inform dosing in hospitalized patients
Patrick O Hanafin, Andrea Kwa, Alexandre P Zavascki, et al.
Mbio
|
February 13, 2020
Novel Cassette Assay To Quantify the Outer Membrane Permeability of Five β-Lactams Simultaneously in Carbapenem-Resistant <i>Klebsiella pneumoniae</i> and <i>Enterobacter cloacae</i>
Tae Hwan Kim, Xun Tao, Bartolome Moya, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 66) with videos related to
Sort By:
Page
of 7
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 24, 2013
Population pharmacokinetics of intravenous polymyxin B in critically ill patients: implications for selection of dosage regimens
Ana M Sandri, Cornelia B Landersdorfer, Jovan Jacob, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 2, 2026
Global Survey on the Management of Multidrug-resistant Gram-negative Bacilli: Divergence of Practice Between High-Income Countries and the Rest of the World
Abi Manesh, Abdullah T Aslan, Mithun Mohan George, et al.
The American Journal of Tropical Medicine and Hygiene
|
July 27, 2022
Evaluation of Clinical Course of Gamma (P.1) Variant of Concern versus Lineages in Hospitalized Patients with COVID-19 in a Reference Center in Brazil
Alexandre P Zavascki, Tarsila Vieceli, Priscila Lamb Wink, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
November 23, 2021
Assessing the predictive performance of population pharmacokinetic models for intravenous polymyxin B in critically ill patients
Patrick O Hanafin, Roger L Nation, Marc H Scheetz, et al.
Antimicrobial Agents and Chemotherapy
|
April 17, 2019
Comparable Efficacy and Better Safety of Double β-Lactam Combination Therapy versus β‑Lactam plus Aminoglycoside in Gram-Negative Bacteria in Randomized, Controlled Trials
Yuanyuan Jiao, Bartolome Moya, Mong-Jen Chen, et al.
Infectious Diseases and Therapy
|
December 12, 2025
Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus Causing Healthcare-Associated Bloodstream Infections in Brazil: Results from A Prospective Countrywide Multicenter Study
Laura C Antochevis, Letícia O Sudbrack, Robson S Leão, et al.
Pharmacotherapy
|
February 3, 2019
International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)
Brian T Tsuji, Jason M Pogue, Alexandre P Zavascki, et al.
Infectious Diseases and Therapy
|
December 15, 2023
A Randomized, Open-Label, Non-inferiority Clinical Trial Assessing 7 Versus 14 Days of Antimicrobial Therapy for Severe Multidrug-Resistant Gram-Negative Bacterial Infections: The OPTIMISE Trial Protocol
Beatriz Arns, Jaqueline Driemeyer C Horvath, Gabriela Soares Rech, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
May 22, 2023
A population pharmacokinetic model of polymyxin B based on prospective clinical data to inform dosing in hospitalized patients
Patrick O Hanafin, Andrea Kwa, Alexandre P Zavascki, et al.
Mbio
|
February 13, 2020
Novel Cassette Assay To Quantify the Outer Membrane Permeability of Five β-Lactams Simultaneously in Carbapenem-Resistant <i>Klebsiella pneumoniae</i> and <i>Enterobacter cloacae</i>
Tae Hwan Kim, Xun Tao, Bartolome Moya, et al.
Page
of 7